Stories
Brokerage Reports: Advice & Targets Issued for 8 Stocks Including Axis Bank, PB Fintech.
- •HSBC and Motilal Oswal adopt cautious stance on PB Fintech; Nomura gives 'Reduce' rating on Meesho.
- •PB Fintech's target reduced by HSBC to ₹1,150 and Motilal Oswal to ₹1,150 due to potential regulatory impact.
- •Nomura issues 'Buy' ratings on CarTrade and Dr. Lal PathLabs, with targets of ₹3,340 and ₹2,150 respectively.
- •HSBC maintains 'Buy' ratings on Axis Bank, IDFC First Bank, Bajaj Finance, and Ujjivan Small Finance Bank.
- •CLSA maintains 'Outperform' rating on Shriram Finance with a target price of ₹1,200.
Key Questions Answered
HSBC downgraded PB Fintech to a 'Hold' rating and reduced its target price from ₹2,100 to ₹1,150 because proposed changes in insurance distribution, particularly caps on commissions, could significantly impact its business and earnings per share estimates for FY2028 and FY2029.
Nomura issued a 'Buy' rating on Dr. Lal PathLabs with a target price of ₹2,150 following the company's agreement to acquire a 70 percent stake in SN Genelab for ₹168 crore, which is expected to strengthen its advanced diagnostics business.
CLSA maintained an 'Outperform' rating on Shriram Finance with a target price of ₹1,200, expecting continued asset growth with a stronger second half for FY2027, steady performance in the used vehicle segment, and a projected 5 to 10 basis point quarterly decrease in funding costs.
